Sorrento Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2008
Revenue	62.84	52.9	39.99	31.43	21.19	151.86	8.15	4.59	3.83	0.46	Upgrade
Revenue Growth (YoY)	18.78%	32.31%	27.21%	48.31%	-86.04%	1762.81%	77.60%	20.00%	731.52%	-21.23%	Upgrade
Cost of Revenue	33.45	13.03	9.94	12.24	7.06	3.95	0.81	1.95	2.04	0	Upgrade
Gross Profit	29.39	39.87	30.05	19.2	14.13	147.91	7.34	2.64	1.78	0.46	Upgrade
Selling, General & Admin	182.34	196.86	116.18	103.56	63.64	38.33	24.22	20.13	9.99	6.32	Upgrade
Research & Development	221.23	206.92	111.34	106.88	76.96	55.53	42.18	31.34	23.98	9.02	Upgrade
Other Operating Expenses	130.14	37.55	47.05	68.15	23.96	28.71	37.72	25.17	2.55	6.79	Upgrade
Operating Expenses	533.7	441.32	274.56	278.59	164.56	122.58	104.12	76.65	36.52	22.12	Upgrade
Operating Income	-504.32	-401.45	-244.52	-259.39	-150.43	25.34	-96.78	-74.01	-34.74	-21.67	Upgrade
Interest Expense / Income	8.57	10.22	20.16	35.05	57.63	4.98	1.61	1.65	1.63	0.25	Upgrade
Other Expense / Income	62.37	50.17	35.8	-1.9	1.76	47.26	-36.57	-66.16	-0.01	-0.01	Upgrade
Pretax Income	-575.26	-461.84	-300.48	-292.54	-209.81	-26.91	-61.82	-9.5	-36.36	-21.91	Upgrade
Income Tax	-2.42	-33.52	-2.01	-0.47	-6.27	-36.04	-0.9	36.31	-1.7	0	Upgrade
Net Income	-572.84	-428.33	-298.46	-292.07	-203.54	9.13	-60.92	-45.81	-34.66	-21.91	Upgrade
Shares Outstanding (Basic)	419	295	230	133	106	70	50	37	27	15	Upgrade
Shares Outstanding (Diluted)	419	295	230	141	106	70	50	37	27	15	Upgrade
Shares Change	42.25%	28.26%	63.56%	32.37%	50.82%	39.76%	36.44%	38.34%	77.32%	31.92%	Upgrade
EPS (Basic)	-1.37	-1.45	-1.30	-2.20	-1.92	0.13	-1.21	-1.24	-1.30	-1.46	Upgrade
EPS (Diluted)	-1.37	-1.45	-1.30	-2.35	-1.92	0.13	-1.21	-1.24	-1.30	-1.46	Upgrade
Free Cash Flow	-307.51	-290.69	-166.06	-184.44	-122.96	-110.15	-77.79	-45.78	-29.36	-16.91	Upgrade
Free Cash Flow Per Share	-0.73	-0.99	-0.72	-1.39	-1.16	-1.58	-1.54	-1.24	-1.10	-1.12	Upgrade
Gross Margin	46.77%	75.37%	75.14%	61.07%	66.69%	97.40%	90.05%	57.52%	46.59%	99.13%	Upgrade
Operating Margin	-802.55%	-758.83%	-611.51%	-825.25%	-709.79%	16.68%	-1187.16%	-1612.31%	-908.29%	-4710.43%	Upgrade
Profit Margin	-911.60%	-809.63%	-746.41%	-929.21%	-960.41%	6.01%	-747.34%	-998.06%	-906.07%	-4763.26%	Upgrade
Free Cash Flow Margin	-489.37%	-549.47%	-415.31%	-586.78%	-580.20%	-72.54%	-954.22%	-997.30%	-767.45%	-3675.87%	Upgrade
EBITDA	-549.21	-435.3	-265.61	-242.45	-142.69	-14.79	-57.32	-5.48	-31.55	-20.37	Upgrade
EBITDA Margin	-874.00%	-822.81%	-664.25%	-771.35%	-673.28%	-9.74%	-703.19%	-119.28%	-824.73%	-4427.83%	Upgrade
Depreciation & Amortization	17.48	16.32	14.71	15.04	9.49	7.14	2.89	2.37	3.18	1.29	Upgrade
EBIT	-566.69	-451.62	-280.32	-257.49	-152.18	-21.93	-60.21	-7.85	-34.73	-21.66	Upgrade
EBIT Margin	-901.80%	-853.65%	-701.04%	-819.21%	-718.08%	-14.44%	-738.58%	-170.92%	-907.97%	-4708.26%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).